Population Covered By The Guidance
This pathway provides guidance on the imaging adult patients with a history of suspected transient ischaemic attack.
Lead Researcher: Bridget Copson, Richard Mendelson
Experts & Contributors: Con Phatourous
Date reviewed: August 2023
Date Published: July 2025
-
Worldwide, there is heterogeneity in the approach to imaging of TIA
-
Multiple international guidelines note the importance of clinical evaluation in a TIA clinic where available.
-
There is overall agreement between international guidelines that carotid imaging (and neuroimaging if performed) should be completed in the acute setting to triage patients who may require early management (suggested within 24 hours)
-
Carotid imaging (with CT angiogram or doppler ultrasound) should be performed to assess for extracranial arterial stenosis or vulnerable plaque.
-
If there is a stenosis > 50% or evidence of vulnerable plaque on doppler ultrasound, a second imaging modality is recommended.
-
While non-stenotic carotid plaque can be a cause for TIA, if there is no significant extracranial stenosis (<50%), further tests to investigate for an alternative cause for emboli should be considered (Echocardiogram/Holter).
-
If there is a stenosis > 50%, referral for consideration of carotid intervention is recommended.
Date of literature search:
September 2023 References are graded from Level I to V according to the Oxford Centre for Evidence-Based Medicine, Levels of Evidence. Download the document
- Fonseca AC, Merwick A, Dennis M, Ferrari J, Ferro JM, Kelly P, et al. European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack. European Stroke Journal. 2021;6(2):CLXIII-CLXXXVI. (Guideline)
- Linden B. National Institute for Health and Care Excellence NG128 stroke and transient ischaemic attack in over 16s: diagnosis and initial management. British Journal of Cardiac Nursing. 2020;15(9):1-5. (Guideline)
- Gladstone DJ, Lindsay MP, Douketis J, Smith EE, Dowlatshahi D, Wein T, et al. Canadian stroke best practice recommendations: secondary prevention of stroke update 2020. Canadian Journal of Neurological Sciences. 2022;49(3):315-37. (Guideline)
- Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364-e467. (Guideline)
- Whiteley WN, MacRaild A, Wang Y, Dennis M, Al-Shahi Salman R, Gray A, et al. Clinical Diagnosis and Magnetic Resonance Imaging in Patients With Transient and Minor Neurological Symptoms: A Prospective Cohort Study. Stroke. 2022;53(11):3419-28. (Level II Evidence)
- Amarenco P, Lavallée PC, Labreuche J, Albers GW, Bornstein NM, Canhão P, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Molina C. One-year risk of stroke after transient ischemic attack or minor stroke. New England Journal of Medicine. 2016 Apr 21;374(16):1533-42. (Level II Evidence)
- Coutts SB, Modi J, Patel SK, Aram H, Demchuk AM, Goyal M, et al. What causes disability after transient ischemic attack and minor stroke? Results from the CT and MRI in the Triage of TIA and minor Cerebrovascular Events to Identify High Risk Patients (CATCH) Study. Stroke. 2012;43(11):3018-22. (Level II evidence)
- Health NIf, Excellence C. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management: National Institute for Health and Care Excellence; 2019. (Guideline)
- Wasserman JK, Perry JJ, Sivilotti ML, Sutherland J, Worster A, Émond M, et al. Computed tomography identifies patients at high risk for stroke after transient ischemic attack/nondisabling stroke: prospective, multicenter cohort study. Stroke. 2015;46(1):114-9. (Level II evidence)
- Hurford R, Li L, Lovett N, Kubiak M, Kuker W, Rothwell PM. Prognostic value of “tissue-based” definitions of TIA and minor stroke: population-based study. Neurology. 2019;92(21):e2455-e61. (Level II evidence)
- Amarenco P. Transient ischemic attack. New England Journal of Medicine. 2020;382(20):1933-41. (Level II Evidence)
- Cassola N, Baptista-Silva JC, Nakano LC, Flumignan CD, Sesso R, Vasconcelos V, et al. Duplex ultrasound for diagnosing symptomatic carotid stenosis in the extracranial segments. Cochrane Database of Systematic Reviews. 2022(7). (Level 1 Evidence)
- Yu A, Coutts S. Role of brain and vessel imaging for the evaluation of transient ischemic attack and minor stroke. Stroke. 2018;49(7):1791-5. (Level II Evidence)
- Forjoe T, Asad Rahi M. Systematic review of preoperative carotid duplex ultrasound compared with computed tomography carotid angiography for carotid endarterectomy. The Annals of The Royal College of Surgeons of England. 2019;101(3):141-9. (Level 1 Evidence)
- Mathiesen EB, Bønaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromsø study. Circulation. 2001;103(17):2171-5. (Level III Evidence)
- Iannuzzi A, Rubba P, Gentile M, Mallardo V, Calcaterra I, Bresciani A, et al. Carotid atherosclerosis, ultrasound and lipoproteins. Biomedicines. 2021;9(5):521. (Level III Evidence)
- Weale AR, Urriza-Rodriguez D. Imaging in vascular disease. Surgery (Oxford). 2015;33(7):308-14. (Level III Evidence)
- Naylor A, Ricco J-B, De Borst G, Debus S, De Haro J, Halliday A, et al. Editor's choice–management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). European Journal of Vascular and Endovascular Surgery. 2018;55(1):3-81. (Guideline)
- Netuka D, Belšán T, Broulíková K, Mandys V, Charvát F, Malík J, et al. Detection of carotid artery stenosis using histological specimens: a comparison of CT angiography, magnetic resonance angiography, digital subtraction angiography and Doppler ultrasonography. Acta neurochirurgica. 2016;158:1505-14. (Level II Evidence)
- Poisson SN, Nguyen-Huynh MN, Johnston SC, Furie KL, Lev MH, Smith WS. Intracranial large vessel occlusion as a predictor of decline in functional status after transient ischemic attack. Stroke. 2011;42(1):44-7. (Level II Evidence)
- Saam T, Hetterich H, Hoffmann V, Yuan C, Dichgans M, Poppert H, et al. Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. Journal of the American College of Cardiology. 2013;62(12):1081-91. (Level I Evidence)
- Gupta A, Baradaran H, Schweitzer AD, Kamel H, Pandya A, Delgado D, et al. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke. 2013;44(11):3071-7. (Level I Evidence)
- Wardlaw J, Chappell F, Stevenson M, De Nigris E, Thomas S, Gillard J, et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technology Assessment (Winchester, England). 2006;10(30):iii-iv, ix. (Level II Evidence)
Pathway User Guide
Yellow Boxes Denotes extra information. Some contain single or multiple white sub-boxes, click a white box to reveal detailed information in a pop-up.
White Boxes: Denotes standard pathway steps. (If inside a yellow box, they open a specific pop-up).
Zoom & Pan Controls: Use + / − or the slider to zoom. Reset returns to default. Tick Panning to drag the diagram when zoomed.
Blue “View Full Screen” Button: Opens the whole diagram in a large, full-screen pop-up window. Use Close to exit.
The relative radiation level (RRL) of each imaging investigation is displayed in the pop up box.
| SYMBOL | RRL | EFFECTIVE DOSE RANGE |
|---|---|---|
| None | 0 | |
| Minimal | < 1 millisieverts | |
| Low | 1-5 mSv | |
| Medium | 5-10 mSv | |
| High | >10 mSv |
Disclaimer
Status Of Recommendations Each pathway is designed to assist clinicians in situations when faced with a large array of possible diagnostic tests and examinations. However, it is recognised that diagnostic practice may differ from a particular pathway depending on local availability of equipment and expertise, as well as the experience of individual clinicians. Therefore each pathway is neither a rigid set of rules, nor a substitute for clinical assessment, and individual patient circumstances should always be considered.
Spotted an error or outdated info? Click to tell us.
Transient ischaemic attack (TIA)
The goals of the diagnostic work-up for TIA are
-
To obtain evidence of a vascular origin for the symptoms [either directly (evidence of hypoperfusion and/or acute infarction) or indirectly (identification of a presumptive source such as a large-vessel stenosis)]
-
To exclude an alternative non-ischaemic origin
-
To ascertain the underlying vascular mechanism of the event (e.g. atherothrombotic, cardioembolic, small-vessel lacunar)
-
To identify prognostic outcome categories
-
There are variations in the definition of Transient Ischaemic Attach (TIA) between international guidelines, a common definition is that of neurological deficits without acute infarction with the European Stroke Guidelines including a time definition of < 24 hours .
-
Worldwide, there is heterogeneity in the approach to imaging of TIA .
-
The aim of imaging and management of TIA is secondary stroke prevention
-
The risk of recurrent stroke is most pronounced in the first few days following symptom onset, thus necessitating prompt risk stratification and appropriate targeted management
-
The ABCD2 risk stratifying tool continues to be used for decision making surrounding medical therapy but is no longer suggested in the risk stratification for the decision surrounding imaging or carotid intervention
Neuroimaging
CT is the standard modality in patients with transient ischaemic attack. The main purpose of the CT Head is to detect ischaemic changes, haemorrhage, tumours etc.
MRI with DWI is more sensitive than standard CT in identifying both new and pre-existing ischaemic lesions in TIA patients
-
Unenhanced CT has traditionally been used as the standard in initial assessment of TIA, to exclude haemorrhage in the setting of consideration of anticoagulation, to exclude alternative pathology and quantify prior infarcts to help with risk prediction.
-
Acute or age indeterminate ischaemia, or microangiopathy diagnosed on unenhanced CT brain is a strong predictor of stroke recurrence .
-
However, there is a paucity of clinical studies to suggest brain imaging after TIA is appropriate or cost effective. Alternatives include referral to a Neurology TIA clinic for assessment and then consideration of MRI brain, particularly in cases of diagnostic uncertainty .
-
Overall, there is no definite evidence to suggest that CT perfusion or MRI will reduce stroke recurrence in TIA .
-
Observational studies suggest that a DWI lesion on MRI is an independent risk factor for stroke recurrence .
-
Changes on DWI imaging of MRI suggest a diagnosis of minor ischaemic stroke (with the absence of disability) .
-
It is acknowledged that whatever neuroimaging and carotid imaging is performed, that this should be done in a short time frame (within 24 hours) so as not to delay potential treatment
Carotid imaging
CT angiography and MR angiography should include head and neck and image the carotid arteries and Circle of Willis (CoW)
-
Choices for initial imaging include:
-
Carotid Doppler ultrasound
-
CT/CT angiography (CTA)
-
MR/MR angiography (MRA)
Each modality has its strengths and weaknesses:
-
CTA (within 3 days of ictus) is generally regarded as the gold standard,
-
However, MR with DWI +/- SWI are very useful adjuncts (see below)
-
Non-stenotic plaques (< 50%) may still be the cause of the TIA and medical treatment is recommended .
Carotid Doppler US
-
Advantages of US include:
-
Collated diagnostic accuracy in a systematic review by Cochrane of duplex ultrasound compared to the gold standard of digital subtraction angiography was high with > 50% stenosis having a summary sensitivity of 0.91 and a summary specificity of 0.70, for >70% stenosis this improved to a summary sensitivity of 0.85 and specificity of 0.98. Summary sensitivity for occlusion was 0.91 and specificity was 0.95
-
Other studies compared CT angiogram (CTA) with ultrasound, and found with the inclusion of end diastolic volume and peak systolic velocity that the sensitivity and specificity of ultrasound was superior to CT angiogram for >70% stenosis (98.7% and 94.1% respectively compared to 90.6 and 93%)
-
Plaque echogenicity,
-
Increased intimal thickness,
-
Neovascularisation and stiffness .
-
Hypoechoic plaques have an increased risk of cerebrovascular event independent of degree of stenosis .
-
-
Widespread availability
-
Portability/ point of care availability
-
Lack of ionising radiation
-
Accuracy for assessment of carotid stenosis
-
Ultrasound has the benefit of noting several high-risk features including:
-
Disadvantages of Doppler US include:
-
Operator dependence,
-
Dependence on patient body habitus
-
Reduced accuracy for calcified plaques
-
Inability to assess the Circle of Willis
-
Unable to assess for tandem lesions
-
Variability in reporting style with relation to plaque morphology
CTA/MRA
-
CT angiography and MR angiography should include the head and neck, and image the carotid arteries and Circle of Willis (CoW)
-
Given there remain limitations of ultrasound, and if a stenosis > 50% is identified, CTA or MR angiogram (MRA) is recommended for confirmation
-
CTA/MRA has benefit of intracranial vascular assessment which provides further prognostication for future vascular events
-
MRA has the advantage of assessing for intra-plaque haemorrhage, the presence of which is associated with high risk for cerebrovascular events .
-
MRA has 92% specificity and ~ 75% sensitivity for detection of severe internal carotid artery stenosis
-
MRI protocol may include DWI and SWI (Susceptibility Weighted Imaging).
-
For any TIA lasting longer than 1 hour there is a 50% chance of detecting DWI hits on DWI.
-
SWI gives information on pial haemosiderosis and cerebral amyloid angiopathy can present with TIA symptoms.
-
DWI is useful as an abnormality identifies the vascular territory of the TIA or if multiple territories are invovled. Occasionally posterior circulation TIAs can mimic clinically an anterior circulation TIA.
-
MRA has a lower resolution than CTA, is more prone to movement artifact and any stenosis over 70% can result in a flow gap and thus is prone to over-estimation
-
CTA may be limited by heavily calcified plaques
-
Carotid intervention/revascularisation may include:
Angioplasty + Carotid Artery Stenting or Carotid Endarterectomy
Non stenotic plaques ( < 50%) may still be the cause of the TIA and medical treatment is recommended .
